Protein kinase inhibitors in the treatment of pulmonary fibrosis

Pharmacology, Toxicology and Pharmaceutical Science

• Antifibrotic Agent 33%
• Apoptosis 100%
• Death 33%
• Disease 100%
• Drug 33%
• Fibrosing Alveolitis 33%
• Fibrosis 66%
• Focal Adhesion Kinase 33%
• Injury 33%
• Janus Kinase 1 33%
• Lung Fibrosis 100%
• Mammal 33%
• Morbidity 33%
• Mortality 33%
• Protein Kinase B 33%
• Protein Kinase Inhibitor 100%
• Protein Kinases 100%
• Respiratory Failure 33%
• Scar 33%
• Skin Injury 33%
• Survival 66%
• Wound Healing 33%